{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:28:26Z","timestamp":1759073306716},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T00:00:00Z","timestamp":1138665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00213-005-0263-5","type":"journal-article","created":{"date-parts":[[2006,1,30]],"date-time":"2006-01-30T11:20:14Z","timestamp":1138620014000},"page":"104-111","source":"Crossref","is-referenced-by-count":10,"title":["The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen"],"prefix":"10.1007","volume":"185","author":[{"given":"Jennifer J.","family":"Wacan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela M.","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristal M.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanders A.","family":"McDougall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,31]]},"reference":[{"key":"263_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(83)90477-6","volume":"91","author":"J Arnt","year":"1983","unstructured":"Arnt J (1983) Differential behavioural effects of dopamine agonists in developing rats: a study of 3-PPP enantiomers. Eur J Pharmacol 91:273\u2013278","journal-title":"Eur J Pharmacol"},{"key":"263_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01249094","volume":"60","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J (1984) Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats. J Neural Transm 60:205\u2013223","journal-title":"J Neural Transm"},{"key":"263_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01245021","volume":"80","author":"J Arnt","year":"1990","unstructured":"Arnt J, Hyttel J (1990) Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques. J Neural Transm 80:33\u201350","journal-title":"J Neural Transm"},{"key":"263_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/cap.2004.14.593","volume":"14","author":"DH Barzman","year":"2004","unstructured":"Barzman DH, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Campbell P, Strakowski SM (2004) The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. J Child Adolesc Psychopharmacol 14:593\u2013600","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"263_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1092852900019489","volume":"10","author":"J Biederman","year":"2005","unstructured":"Biederman J, McDonnell MA, Wozniak J, Spencer T, Aleardi M, Falzone R, Mick E (2005) Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr 10:141\u2013148","journal-title":"CNS Spectr"},{"key":"263_CR6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","volume":"302","author":"KD Burris","year":"2002","unstructured":"Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381\u2013389","journal-title":"J Pharmacol Exp Ther"},{"key":"263_CR7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","volume":"196","author":"DR Burt","year":"1977","unstructured":"Burt DR, Creese I, Snyder SH (1977) Antipsychotic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326\u2013328","journal-title":"Science"},{"key":"263_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01249001","volume":"57","author":"A Carlsson","year":"1983","unstructured":"Carlsson A (1983) Dopamine receptor agonists: intrinsic activity vs. state of the receptor. J Neural Transm 57:309\u2013315","journal-title":"J Neural Transm"},{"key":"263_CR9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0091-3057(87)90509-0","volume":"28","author":"RE Chipkin","year":"1987","unstructured":"Chipkin RE, McQuade RD, Iorio LC (1987) D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy. Pharmacol Biochem Behav 28:477\u2013482","journal-title":"Pharmacol Biochem Behav"},{"key":"263_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01260414","volume":"62","author":"D Clark","year":"1985","unstructured":"Clark D, Hjorth S, Carlsson A (1985a) Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. J Neural Transm 62:1\u201352","journal-title":"J Neural Transm"},{"key":"263_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01252236","volume":"62","author":"D Clark","year":"1985","unstructured":"Clark D, Hjorth S, Carlsson A (1985b) Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J Neural Transm 62:171\u2013207","journal-title":"J Neural Transm"},{"key":"263_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF02244434","volume":"105","author":"D Clark","year":"1991","unstructured":"Clark D, Furmidge LJ, Petry N, Tong Z-Y, Ericsson M, Johnson D (1991) Behavioural profile of partial D2 dopamine receptor agonists. I. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy. Psychopharmacology (Berl) 105:381\u2013392","journal-title":"Psychopharmacology (Berl)"},{"key":"263_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0024-3205(90)90293-Z","volume":"47","author":"B Drukarch","year":"1990","unstructured":"Drukarch B, Stoof JC (1990) D-2 dopamine autoreceptor selective drugs: do they really exist? Life Sci 47:361\u2013376","journal-title":"Life Sci"},{"issue":"Suppl 4","key":"263_CR14","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1016\/S0924-977X(03)92080-3","volume":"13","author":"RL Findling","year":"2003","unstructured":"Findling RL, Blumer J, Kauffman R, Batterson J, Gilbert D, Bramer S, Marcus R (2003) Aripiprazole in pediatric conduct disorder: a pilot study. Eur Neuropsychopharmacol 13(Suppl 4):S335","journal-title":"Eur Neuropsychopharmacol"},{"key":"263_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00428999","volume":"81","author":"S Hjorth","year":"1983","unstructured":"Hjorth S, Carlsson A, Clark D, Svensson K, Wikstrom H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A, Nilsson JLG (1983) Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology (Berl) 81:89\u201399","journal-title":"Psychopharmacology (Berl)"},{"key":"263_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(88)90715-7","volume":"152","author":"S Hjorth","year":"1988","unstructured":"Hjorth S, Clark D, Carlsson A (1988) Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. Eur J Pharmacol 152:207\u2013215","journal-title":"Eur J Pharmacol"},{"key":"263_CR17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0165-6147(93)90129-8","volume":"14","author":"D Hoyer","year":"1993","unstructured":"Hoyer D, Boddeke HWGM (1993) Partial agonists, full agonists: dilemmas of definition. Trends Pharmacol Sci 14:270\u2013275","journal-title":"Trends Pharmacol Sci"},{"key":"263_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-4886(91)90017-7","volume":"113","author":"JN Joyce","year":"1991","unstructured":"Joyce JN (1991) Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment. Exp Neurol 113:277\u2013290","journal-title":"Exp Neurol"},{"key":"263_CR19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/WNL.37.4.723","volume":"37","author":"WC Kohler","year":"1987","unstructured":"Kohler WC, Herbster G (1987) Terguride, a mixed dopamine agonist\u2013antagonist, in animal models of Parkinson\u2019s disease. Neurology 37:723\u2013727","journal-title":"Neurology"},{"key":"263_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/syn.890120103","volume":"12","author":"GJ LaHoste","year":"1992","unstructured":"LaHoste GJ, Marshall JF (1992) Dopamine supersensitivity and D1\/D2 synergism are unrelated to changes in striatal receptor density. Synapse 12:14\u201326","journal-title":"Synapse"},{"key":"263_CR21","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1073\/pnas.90.16.7451","volume":"90","author":"GJ LaHoste","year":"1993","unstructured":"LaHoste GJ, Yu J, Marshall JF (1993) Striatal Fos expression is indicative of dopamine D1\/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 90:7451\u20137455","journal-title":"Proc Natl Acad Sci USA"},{"key":"263_CR22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","volume":"20","author":"CP Lawler","year":"1999","unstructured":"Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20:612\u2013627","journal-title":"Neuropsychopharmacology"},{"key":"263_CR23","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1073\/pnas.81.12.3910","volume":"81","author":"SE Leff","year":"1984","unstructured":"Leff SE, Gariano R, Creese I (1984) Dopamine receptor turnover rates are age-dependent. Proc Natl Acad Sci USA 81:3910\u20133914","journal-title":"Proc Natl Acad Sci USA"},{"key":"263_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-004-2033-1","volume":"178","author":"SA McDougall","year":"2005","unstructured":"McDougall SA, Hernandez RM, Reichel CM, Farley CM (2005) The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats. Psychopharmacology (Berl) 178:431\u2013439","journal-title":"Psychopharmacology (Berl)"},{"key":"263_CR25","first-page":"592","volume":"31","author":"E Meller","year":"1987","unstructured":"Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M (1987) Relationship between receptor occupancy and response at striatal autoreceptors. Mol Pharmacol 31:592\u2013598","journal-title":"Mol Pharmacol"},{"key":"263_CR26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(88)90413-X","volume":"155","author":"E Meller","year":"1988","unstructured":"Meller E, Enz A, Goldstein M (1988) Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity. Eur J Pharmacol 155:151\u2013154","journal-title":"Eur J Pharmacol"},{"key":"263_CR27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02244963","volume":"107","author":"CA Moody","year":"1992","unstructured":"Moody CA, Spear LP (1992) Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups. Psychopharmacology (Berl) 107:39\u201349","journal-title":"Psychopharmacology (Berl)"},{"key":"263_CR28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1017\/S1461145705005365","volume":"8","author":"TK Murphy","year":"2005","unstructured":"Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M (2005) Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 8:489\u2013490","journal-title":"Int J Neuropsychopharmacol"},{"key":"263_CR29","volume-title":"Guidelines for the care and use of mammals in neuroscienceand behavioral research","author":"National Research Council","year":"2003","unstructured":"National Research Council (2003) Guidelines for the care and use of mammals in neuroscienceand behavioral research. National Academy Press, Washington, DC"},{"key":"263_CR30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0893-133X(01)00270-6","volume":"25","author":"C Orsini","year":"2001","unstructured":"Orsini C, Koob GF, Pulvirenti L (2001) Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25:789\u2013792","journal-title":"Neuropsychopharmacology"},{"key":"263_CR31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0165-6147(94)90158-9","volume":"15","author":"L Pulvirenti","year":"1994","unstructured":"Pulvirenti L, Koob GF (1994) Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 15:374\u2013379","journal-title":"Trends Pharmacol Sci"},{"key":"263_CR32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2999(88)90121-5","volume":"148","author":"M Rubinstein","year":"1988","unstructured":"Rubinstein M, Gershanik O, Stefano FJ (1988) Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice. Eur J Pharmacol 148:419\u2013426","journal-title":"Eur J Pharmacol"},{"key":"263_CR33","first-page":"810","volume":"252","author":"M Rubinstein","year":"1990","unstructured":"Rubinstein M, Muschietti JP, Gershanik O, Flawia MM, Stefano FJ (1990) Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice. J Pharmacol Exp Ther 252:810\u2013816","journal-title":"J Pharmacol Exp Ther"},{"key":"263_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0091-3057(03)00188-6","volume":"76","author":"JM Sibole","year":"2003","unstructured":"Sibole JM, Matea PJ, Krall CM, McDougall SA (2003) Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats. Pharmacol Biochem Behav 76:27\u201334","journal-title":"Pharmacol Biochem Behav"},{"key":"263_CR35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cap.2004.14.455","volume":"14","author":"KA Stigler","year":"2004","unstructured":"Stigler KA, Posey DJ, McDougle CJ (2004) Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol 14:455\u2013463","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"263_CR36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00182999","volume":"344","author":"K Svensson","year":"1991","unstructured":"Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A (1991) Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study. Naunyn Schmiedebergs Arch Pharmacol 344:263\u2013274","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"263_CR37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0024-3205(83)90089-9","volume":"32","author":"H Wachtel","year":"1983","unstructured":"Wachtel H, Dorow R (1983) Dual action on central dopamine function of transdihydrolisuride, a 9,10-dihydrogenated analogue of the ergot dopamine agonist lisuride. Life Sci 32:421\u2013432","journal-title":"Life Sci"},{"key":"263_CR38","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1007\/BF00507058","volume":"325","author":"H Wachtel","year":"1984","unstructured":"Wachtel H, Rettig K-J, Seltz A (1984) The central dopamine agonistic action of transdihydrolisuride is unmasked at supersensitive receptors. Naunyn Schmiedebergs Arch Pharmacol 325:R80","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"263_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1098-2302(199703)30:2<141::AID-DEV5>3.0.CO;2-Q","volume":"30","author":"EP Zorrilla","year":"1997","unstructured":"Zorrilla EP (1997) Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol 30:141\u2013150","journal-title":"Dev Psychobiol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-0263-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0263-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:31:11Z","timestamp":1558614671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-0263-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,31]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["263"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-0263-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,31]]}}}